New acne pill tested for Long-Term safety in 240 patients
NCT ID NCT06248008
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 23 times
Summary
This study tested the long-term safety of a daily pill called ASC40 (Denifanstat) in 240 people with moderate to severe acne. Participants took the drug for up to 40 weeks and were monitored for side effects through blood tests and checkups. The goal was to see if the treatment is safe to use over a longer period.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.